At a glance
Recurrent vertigo attacks in people with a history of migraine, linked to migraine mechanisms; a vestibular disorder of central origin.
Attacks last 5 minutes to 72 hours; at least half are accompanied by headache, sensitivity to light and sound, or visual aura.
Usually not urgent; other causes should be sought if there is permanent or progressive hearing loss, a new neurological sign or an unusually severe attack.
Trigger management is the mainstay; preventive medication and vestibular rehabilitation can be added when attacks are frequent.
Medical disclaimer. This content is for informational purposes only and does not replace a physician’s examination, diagnosis or treatment; it should not be used as medical advice. For your complaints or personal situation, always consult an ear, nose and throat physician and an audiologist.
If you have a history of migraine and recurrent attacks of dizziness, especially with headache, sensitivity to light and sound, or visual aura, see a doctor. If the dizziness comes with permanent or progressive hearing loss, Ménière’s disease and other causes need to be investigated. If you develop sudden double vision, slurred speech or weakness in an arm or leg, go to the emergency department without delay.
Definition and epidemiology
Vestibular migraine (VM) is a disorder of central origin defined by recurrent vestibular attacks that occur in people with a history of migraine and are linked to migraine mechanisms. Its diagnostic criteria were developed jointly by the Bárány Society and the International Headache Society and were left unchanged in the 2022 update (Lempert et al., 2022).
A population-based study found a lifetime prevalence of about 1% (Neuhauser et al., 2006). VM is more common in women. Although it is a frequent cause of episodic vertigo, the diagnosis is often delayed or missed (Lempert et al., 2012).
Symptoms and signs
Attacks last from 5 minutes to 72 hours. The vestibular symptom may be spontaneous vertigo, positional vertigo, visually induced vertigo or head-motion-induced dizziness with nausea (Lempert et al., 2022).
At least half of the attacks are accompanied by a migraine feature: migraine-type headache, photophobia and phonophobia, or visual aura. Headache need not occur with every attack; the dizziness may come before, with or independently of the headache. Mild, transient auditory symptoms can occur, but permanent or progressive hearing loss is not expected.
Causes and risk factors
The mechanism of VM is not fully understood; the central mechanisms involved in migraine are thought to affect the vestibular pathways and the inner ear. Genetic predisposition has also been proposed (Stolte et al., 2015).
Reported triggers include stress, irregular sleep, skipped meals, menstruation and hormonal changes, intense visual stimulation and certain foods and drinks. Triggers vary from person to person.
Audiological and clinical assessment
The diagnosis rests on the history and requires other causes to be excluded. ‘Definite VM’ requires at least five vestibular episodes of moderate or severe intensity lasting 5 minutes to 72 hours, a current or past history of migraine meeting ICHD criteria, and at least one migraine feature in at least half of the episodes. Patients who meet only part of the criteria are classed as ‘probable VM’ (Lempert et al., 2022).
- Videonystagmography (VNG), caloric testing and vHIT: mostly normal between attacks or showing only mild, non-specific findings; spontaneous or positional nystagmus may be seen during an attack (Stolte et al., 2015).
- VEMP: there is no finding specific to VM.
- Pure-tone audiometry: usually normal. If a fluctuating low-frequency loss is found, Ménière’s disease should be investigated.
- Imaging: MRI is requested to exclude other central causes when the course is atypical or there are central signs.
| Feature | Vestibular migraine | Ménière’s disease |
|---|---|---|
| Attack duration | 5 min-72 h | 20 min-12 h |
| Hearing | Usually preserved | Fluctuating low-frequency loss |
| Migraine features | In at least half of attacks | Uncommon |
| Vestibular tests | Mostly normal between attacks | Often abnormal |
| Main approach | Trigger management, prevention | Lifestyle, medication, procedures |
Treatment and audiological rehabilitation
During an attack, short-term medication can ease nausea and dizziness. When attacks are frequent or severe, drugs used for migraine prevention are tried. However, placebo-controlled evidence on preventive drugs in VM is very limited, with only low-certainty data for beta-blockers and calcium channel blockers (Webster et al., 2023). The choice of medication rests with the physician.
Regular sleep and meals, stress management and avoiding personal triggers form the basis of management. Vestibular rehabilitation can help with imbalance and motion-related symptoms that persist between attacks.
Impact on quality of life and advice
Because attacks are unpredictable, anxiety and fear of falling can reduce quality of life, and some patients go on to develop Persistent Postural-Perceptual Dizziness (PPPD). An accurate diagnosis frees patients from uncertainty and leads them to appropriate treatment.
Keeping a diary of sleep, meals, stress and possible triggers, and exercising regularly, are recommended. Resting in a dim, quiet room during an attack can ease the symptoms.
If you used this review, you can cite it as follows (APA 7):
Auditory Scene. (2026). Vestibular Migraine. Hearing & Balance Health Guide. https://auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/vestibuler-migren/Permanent link: auditoryscene.com/guncel-haberler/categories/isitme-sagligi-rehberi/vestibuler-migren/ · Last reviewed: October 2026 · License: CC BY-NC-ND 4.0
References
- Lempert, T., Olesen, J., Furman, J., et al. (2012). Vestibular migraine: Diagnostic criteria. Journal of Vestibular Research, 22(4), 167-172.
- Lempert, T., Olesen, J., Furman, J., et al. (2022). Vestibular migraine: Diagnostic criteria. Journal of Vestibular Research, 32(1), 1-6.
- Neuhauser, H. K., Radtke, A., von Brevern, M., et al. (2006). Migrainous vertigo: Prevalence and impact on quality of life. Neurology, 67(6), 1028-1033.
- Stolte, B., Holle, D., Naegel, S., et al. (2015). Vestibular migraine. Cephalalgia, 35(3), 262-270.
- Webster, K. E., Dor, A., Galbraith, K., et al. (2023). Pharmacological interventions for prophylaxis of vestibular migraine. Cochrane Database of Systematic Reviews, 2023(4), CD015187.
Frequently asked questions
Can I have vestibular migraine without a headache?
Yes. Not every attack of vestibular migraine has to come with a headache. In some attacks the dizziness is accompanied only by sensitivity to light and sound or by visual aura. The absence of headache therefore does not rule out the diagnosis.
How is vestibular migraine told apart from Ménière’s disease?
Both cause attacks of dizziness. Ménière’s disease leads to a fluctuating low-frequency hearing loss that becomes permanent over time, whereas in vestibular migraine hearing is usually preserved and migraine symptoms are prominent. The distinction is made from the history and hearing tests, and the two conditions can coexist.
Does diet really affect the attacks?
In some patients skipped meals, irregular sleep and certain foods and drinks can trigger attacks. Triggers are not the same for everyone; keeping a diary to identify your own can help reduce how often attacks occur.
Can exercise trigger attacks?
During an attack, sudden or rapid movements can make symptoms worse. Between attacks, balance exercises guided by a specialist and regular physical activity support recovery and are recommended.
Does it respond well to treatment?
In most patients, trigger management, preventive treatment where needed and vestibular rehabilitation reduce the frequency and severity of attacks. Because strong evidence for preventive drugs is limited, treatment is tailored to the individual and adjusted according to the response.
Scales that can be used to monitor vestibular-migraine diagnosis and the impact of dizziness:
Auditory Scene